Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia

We present the case of a 46-year-old woman with sympathetic ophthalmia occurring 27 years after complicated juvenile cataract surgeries. The patient declined systemic immunosuppressive therapy. Dexamethasone implant in the sympathizing eye allowed good visual recovery up to 18 months of follow-up wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Mansour, Ahmad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006629/
https://www.ncbi.nlm.nih.gov/pubmed/29928220
http://dx.doi.org/10.1159/000488850
_version_ 1783332873660530688
author Mansour, Ahmad M.
author_facet Mansour, Ahmad M.
author_sort Mansour, Ahmad M.
collection PubMed
description We present the case of a 46-year-old woman with sympathetic ophthalmia occurring 27 years after complicated juvenile cataract surgeries. The patient declined systemic immunosuppressive therapy. Dexamethasone implant in the sympathizing eye allowed good visual recovery up to 18 months of follow-up with a total of 6 implants. Intraocular pressure rise was controlled medically. This is a unique report of sympathetic ophthalmia treated solely with slow-release dexamethasone implant without systemic therapies.
format Online
Article
Text
id pubmed-6006629
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-60066292018-06-20 Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia Mansour, Ahmad M. Case Rep Ophthalmol Case Report We present the case of a 46-year-old woman with sympathetic ophthalmia occurring 27 years after complicated juvenile cataract surgeries. The patient declined systemic immunosuppressive therapy. Dexamethasone implant in the sympathizing eye allowed good visual recovery up to 18 months of follow-up with a total of 6 implants. Intraocular pressure rise was controlled medically. This is a unique report of sympathetic ophthalmia treated solely with slow-release dexamethasone implant without systemic therapies. S. Karger AG 2018-05-22 /pmc/articles/PMC6006629/ /pubmed/29928220 http://dx.doi.org/10.1159/000488850 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Mansour, Ahmad M.
Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title_full Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title_fullStr Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title_full_unstemmed Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title_short Dexamethasone Implant as Sole Therapy in Sympathetic Ophthalmia
title_sort dexamethasone implant as sole therapy in sympathetic ophthalmia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006629/
https://www.ncbi.nlm.nih.gov/pubmed/29928220
http://dx.doi.org/10.1159/000488850
work_keys_str_mv AT mansourahmadm dexamethasoneimplantassoletherapyinsympatheticophthalmia

Ejemplares similares